Interactions between organic anions on multiple transporters in Caco-2 cells

Journal of Pharmaceutical Sciences

Volumn 100, Issue 9, 2011, Pages 3817-3830

  Grandvuinet, Anne Sophie ^a   Steffansen, Bente ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Caco 2 cells; Drug interactions; Drug transport; Estrone 3 sulfate; Membrane transporter; Organic anions; Permeability; Taurocholic acid

Indexed keywords

APICAL SODIUM DEPENDENT BILE ACID TRANSPORTER; CARRIER PROTEIN; ESTRONE SULFATE; FLUINDOSTATIN; GLIPIZIDE; MULTIDRUG RESISTANCE PROTEIN 2; MULTIDRUG RESISTANCE PROTEIN 3; ORGANIC ANION TRANSPORTER; ORGANIC ANION TRANSPORTING POLYPEPTIDE 2B1; ORGANIC SOLUTE TRANSPORTER ALPHA; ORGANIC SOLUTE TRANSPORTER BETA; TAUROCHOLIC ACID; TAUROLITHOCHOLIC ACID; UNCLASSIFIED DRUG;

ARTICLE; CELL MEMBRANE PERMEABILITY; CELL STRAIN CACO 2; CONTROLLED STUDY; HUMAN; HUMAN CELL; INTESTINE; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT;

EID: 79960113405     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22632     Document Type: Article

References (56)

1. Food and Drug Administration. 2006. Drug interaction studies-Study design, data analysis, and implications for dosing and labeling. Guidance for industry (draft).
2. European Medicines Agency. 2010. Guideline on the investigation of drug interactions (draft).
3. Hidalgo IJ, Raub TJ, Borchardt RT. 1989. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 96:736-749.
4. Maubon N, Le VM, Fossati L, Audry M, Le FE, Bolze S, Fardel O. 2007. Analysis of drug transporter expression in human intestinal Caco-2 cells by real-time PCR. Fundam Clin Pharmacol 21:659-663.
5. Hayeshi R, Hilgendorf C, Artursson P, Augustijns P, Brodin B, Dehertogh P, Fisher K, Fossati L, Hovenkamp E, Korjamo T, Masungi C, Maubon N, Mols R, Mullertz A, Monkkonen J, O'Driscoll C, Oppers-Tiemissen HM, Ragnarsson EG, Rooseboom M, Ungell AL. 2008. Comparison of drug transporter gene expression and functionality in Caco-2 cells from 10 different laboratories. Eur J Pharm Sci 35:383-396.
6. Sun H, Chow EC, Liu S, Du Y, Pang KS. 2008. The Caco-2 cell monolayer: Usefulness and limitations. Expert Opin Drug Metab Toxicol 4:395-411.
7. Ahlin G, Hilgendorf C, Karlsson J, Szigyarto CA, Uhlen M, Artursson P. 2009. Endogenous gene and protein expression of drug-transporting proteins in cell lines routinely used in drug discovery programs. Drug Metab Dispos 37:2275-2283.
8. Giacomini KM, Huang SM, Tweedie DJ, Benet LZ, Brouwer KL, Chu X, Dahlin A, Evers R, Fischer V, Hillgren KM, Hoffmaster KA, Ishikawa T, Keppler D, Kim RB, Lee CA, Niemi M, Polli JW, Sugiyama Y, Swaan PW, Ware JA, Wright SH, Yee SW, Zamek-Gliszczynski MJ, Zhang L. 2010. Membrane transporters in drug development. Nat Rev Drug Discov 9:215-236.
9. Xia CQ, Milton MN, Gan LS. 2007. Evaluation of drug-transporter interactions using in vitro and in vivo models. Curr Drug Metab 8:341-363.
10. Jin H, Di L. 2008. Permeability-In vitro assays for assessing drug transporter activity. Curr Drug Metab 9:911-920.
11. Hilgendorf C, Ahlin G, Seithel A, Artursson P, Ungell AL, Karlsson J. 2007. Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines. Drug Metab Dispos 35:1333-1340.
12. Kobayashi D, Nozawa T, Imai K, Nezu J, Tsuji A, Tamai I. 2003. Involvement of human organic anion transporting polypeptide OATP-B (SLC21A9) in pH-dependent transport across intestinal apical membrane. J Pharmacol Exp Ther 306:703-708.
13. Hagenbuch B, Gui C. 2008. Xenobiotic transporters of the human organic anion transporting polypeptides (OATP) family. Xenobiotica 38:778-801.
14. Geyer J, Wilke T, Petzinger E. 2006. The solute carrier family SLC10: More than a family of bile acid transporters regarding function and phylogenetic relationships. Naunyn Schmiedebergs Arch Pharmacol 372:413-431.
15. Choudhuri S, Klaassen CD. 2006. Structure, function, expression, genomic organization, and single nucleotide polymorphisms of human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) efflux transporters. Int J Toxicol 25:231-259.
16. Doyle LA, Yang W, Abruzzo LV, Krogmann T, Gao Y, Rishi AK, Ross DD. 1998. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci U S A 95:15665-15670.
17. Mao Q, Unadkat JD. 2005. Role of the breast cancer resistance protein (ABCG2) in drug transport. AAPS J 7:E118-E133.
18. Mottino AD, Hoffman T, Jennes L, Vore M. 2000. Expression and localization of multidrug resistant protein mrp2 in rat small intestine. J Pharmacol Exp Ther 293:717-723.
19. Dawson PA, Hubbert M, Haywood J, Craddock AL, Zerangue N, Christian WV, Ballatori N. 2005. The heteromeric organic solute transporter alpha-beta, Ostalpha-Ostbeta, is an ileal basolateral bile acid transporter. J Biol Chem 280:6960-6968.
20. Ballatori N, Christian WV, Lee JY, Dawson PA, Soroka CJ, Boyer JL, Madejczyk MS, Li N. 2005. OSTalpha-OSTbeta: A major basolateral bile acid and steroid transporter in human intestinal, renal, and biliary epithelia. Hepatology 42:1270-1279.
21. Kiuchi Y, Suzuki H, Hirohashi T, Tyson CA, Sugiyama Y. 1998. cDNA cloning and inducible expression of human multidrug resistance associated protein 3 (MRP3). FEBS Lett 433:149-152.
22. van Breemen RB, Li Y. 2005. Caco-2 cell permeability assays to measure drug absorption. Expert Opin Drug Metab Toxicol 1:175-185.
23. Artursson P, Palm K, Luthman K. 2001. Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv Drug Deliv Rev 46:27-43.
24. Hirano M, Maeda K, Matsushima S, Nozaki Y, Kusuhara H, Sugiyama Y. 2005. Involvement of BCRP (ABCG2) in the biliary excretion of pitavastatin. Mol Pharmacol 68:800-807.
25. Noe J, Portmann R, Brun ME, Funk C. 2007. Substrate-dependent drug-drug interactions between gemfibrozil, fluvastatin and other organic anion-transporting peptide (OATP) substrates on OATP1B1, OATP2B1, and OATP1B3. Drug Metab Dispos 35:1308-1314.
26. Zheng X, Ekins S, Raufman JP, Polli JE. 2009. Computational models for drug inhibition of the human apical sodium-dependent bile acid transporter. Mol Pharm 6:1591-1603.
27. Antonilli M, Bottari E, Festa MR. 2007. Taurocholate and taurodeoxycholate: Gel formation and protonation constants. Ann Chim 97:39-48.
28. Sarbu C, Onisor C, Posa M, Kevresan S, Kuhajda K. 2008. Modeling and prediction (correction) of partition coefficients of bile acids and their derivatives by multivariate regression methods. Talanta 75:651-657.
29. Kaler G, Truong DM, Khandelwal A, Nagle M, Eraly SA, Swaan PW, Nigam SK. 2007. Structural variation governs substrate specificity for organic anion transporter (OAT) homologs. Potential remote sensing by OAT family members. J Biol Chem 282:23841-23853.
30. Gram LK, Rist GM, Lennernas H, Steffansen B. 2009. Impact of carriers in oral absorption: Permeation across Caco-2 cells for the organic anions estrone-3-sulfate and glipizide. Eur J Pharm Sci 37:378-386.
31. Hofmann AF, Roda A. 1984. Physicochemical properties of bile acids and their relationship to biological properties: An overview of the problem. J Lipid Res 25:1477-1489.
32. Roda A, Hofmann AF, Mysels KJ. 1983. The influence of bile salt structure on self-association in aqueous solutions. J Biol Chem 258:6362-6370.
33. Winiwarter S, Bonham NM, Ax F, Hallberg A, Lennernas H, Karlen A. 1998. Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach. J Med Chem 41:4939-4949.
34. Skold C, Winiwarter S, Wernevik J, Bergstrom F, Engstrom L, Allen R, Box K, Comer J, Mole J, Hallberg A, Lennernas H, Lundstedt T, Ungell AL, Karlen A. 2006. Presentation of a structurally diverse and commercially available drug data set for correlation and benchmarking studies. J Med Chem 49:6660-6671.
35. Wang Q, Strab R, Kardos P, Ferguson C, Li J, Owen A, Hidalgo IJ. 2008. Application and limitation of inhibitors in drug-transporter interactions studies. Int J Pharm 356:12-18.
36. Hidalgo IJ, Borchardt RT. 1990. Transport of bile acids in a human intestinal epithelial cell line, Caco-2. Biochim Biophys Acta 1035:97-103.
37. Wilson G, Hassan IF, Dix CJ, Williamson I, Shah R, Mackay M, Artursson P. 1990. Transport and permeability properties of human Caco-2 cells: An in vitro model of the intestinal epithelial cell barrier. J Control Release 11:25-40.
38. Craddock AL, Love MW, Daniel RW, Kirby LC, Walters HC, Wong MH, Dawson PA. 1998. Expression and transport properties of the human ileal and renal sodium-dependent bile acid transporter. Am J Physiol 274:G157-G169.
39. Sai Y, Kaneko Y, Ito S, Mitsuoka K, Kato Y, Tamai I, Artursson P, Tsuji A. 2006. Predominant contribution of organic anion transporting polypeptide OATP-B (OATP2B1) to apical uptake of estrone-3-sulfate by human intestinal Caco-2 cells. Drug Metab Dispos 34:1423-1431.
40. Nozawa T, Imai K, Nezu J, Tsuji A, Tamai I. 2004. Functional characterization of pH-sensitive organic anion transporting polypeptide OATP-B in human. J Pharmacol Exp Ther 308:438-445.
41. Hirano M, Maeda K, Shitara Y, Sugiyama Y. 2006. Drug-drug interaction between pitavastatin and various drugs via OATP1B1. Drug Metab Dispos 34:1229-1236.
42. Geyer J, Doring B, Meerkamp K, Ugele B, Bakhiya N, Fernandes CF, Godoy JR, Glatt H, Petzinger E. 2007. Cloning and functional characterization of human sodium-dependent organic anion transporter (SLC10A6). J Biol Chem 282:19728-19741.
43. Seward DJ, Koh AS, Boyer JL, Ballatori N. 2003. Functional complementation between a novel mammalian polygenic transport complex and an evolutionarily ancient organic solute transporter, OSTalpha-OSTbeta. J Biol Chem 278:27473-27482.
44. Tamai I, Nezu J, Uchino H, Sai Y, Oku A, Shimane M, Tsuji A. 2000. Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family. Biochem Biophys Res Commun 273:251-260.
45. Adachi H, Suzuki T, Abe M, Asano N, Mizutamari H, Tanemoto M, Nishio T, Onogawa T, Toyohara T, Kasai S, Satoh F, Suzuki M, Tokui T, Unno M, Shimosegawa T, Matsuno S, Ito S, Abe T. 2003. Molecular characterization of human and rat organic anion transporter OATP-D. Am J Physiol Renal Physiol 285:F1188-F1197.
46. Lindahl A, Sjoberg A, Bredberg U, Toreson H, Ungell AL, Lennernas H. 2004. Regional intestinal absorption and biliary excretion of fluvastatin in the rat: Possible involvement of mrp2. Mol Pharm 1:347-356.
47. Imai Y, Asada S, Tsukahara S, Ishikawa E, Tsuruo T, Sugimoto Y. 2003. Breast cancer resistance protein exports sulfated estrogens but not free estrogens. Mol Pharmacol 64:610-618.
48. Suzuki M, Suzuki H, Sugimoto Y, Sugiyama Y. 2003. ABCG2 transports sulfated conjugates of steroids and xenobiotics. J Biol Chem 278:22644-22649.
49. Prime-Chapman HM, Fearn RA, Cooper AE, Moore V, Hirst BH. 2004. Differential multidrug resistance-associated protein 1 through 6 isoform expression and function in human intestinal epithelial Caco-2 cells. J Pharmacol Exp Ther 311:476-484.
50. Bock-Hennig BS, Kohle C, Nill K, Bock KW. 2002. Influence of t-butylhydroquinone and beta-naphthoflavone on formation and transport of 4-methylumbelliferone glucuronide in Caco-2/TC-7 cell monolayers. Biochem Pharmacol 63:123-128.
51. Hirohashi T, Suzuki H, Takikawa H, Sugiyama Y. 2000. ATP-dependent transport of bile salts by rat multidrug resistance-associated protein 3 (Mrp3). J Biol Chem 275:2905-2910.
52. Hirohashi T, Suzuki H, Sugiyama Y. 1999. Characterization of the transport properties of cloned rat multidrug resistance-associated protein 3 (MRP3). J Biol Chem 274:15181-15185.
53. Zeng H, Liu G, Rea PA, Kruh GD. 2000. Transport of amphipathic anions by human multidrug resistance protein 3. Cancer Res 60:4779-4784.
54. Akita H, Suzuki H, Hirohashi T, Takikawa H, Sugiyama Y. 2002. Transport activity of human MRP3 expressed in Sf9 cells: Comparative studies with rat MRP3. Pharm Res 19:34-41.
55. Zelcer N, Saeki T, Bot I, Kuil A, Borst P. 2003. Transport of bile acids in multidrug-resistance-protein 3-overexpressing cells co-transfected with the ileal Na+-dependent bile-acid transporter. Biochem J 369:23-30.
56. Steffansen B, Rolsted K, Rapin N, Steffansen B. Simulating kinetic parameters in transporter mediated permeability across Caco-2 cells. A case study of estrone-3-sulfate (submitted). Eur J Pharm Sci.